About 1 in 3 American Adults Has an Allergy
THURSDAY, Jan. 26, 2023 (HealthDay News) -- If it seems as though everyone you know struggles with some sort of allergy, new research suggests you are not mistaken.
Stay updated with breaking news from Peter Lio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
THURSDAY, Jan. 26, 2023 (HealthDay News) -- If it seems as though everyone you know struggles with some sort of allergy, new research suggests you are not mistaken.
Having a good relationship with your doctor is one of the most important aspects of the treatment you get ....
Ariah Dhaliwal, from Illinois, was one of 162 preschoolers recruited to a clinical trial for new treatment Dupixent which could help eczema sufferers by calming their immune system.
Scientists at Northwestern University in Illinois , found the monoclonal antibody Dupilumab - sold under the brand name Dupixent - cut eczema symptoms by at least 75 percent in half of children.
Baricitinib 4 mg met the primary endpoint in a phase 3 study involving patients with AD who had failed or could not take cyclosporine.